v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Net sales $ 898 $ 936 $ 1,778 $ 1,815
Cost of products sold 405 446 858 859
Gross profit 493 490 920 956
Selling, general, and administrative expenses 364 342 715 700
Research and development expenses 45 37 89 73
Goodwill and intangible asset impairments 0 235 0 235
Restructuring and other costs 2 4 69 13
Operating income (loss) 82 (128) 47 (65)
Other income and expenses:        
Interest expense, net 22 24 46 43
Other (income) expense, net (12) 1 (29) 1
Income (loss) before income taxes 72 (153) 30 (109)
Provision (benefit) for income taxes 36 (109) 4 (84)
Net income (loss) 36 (44) 26 (25)
Less: Net (loss) income attributable to noncontrolling interest (1) 1 (1) 0
Net income (loss) attributable to Dentsply Sirona $ 37 $ (45) $ 27 $ (25)
Earnings (loss) per common share attributable to Dentsply Sirona:        
Basic (in dollars per share) $ 0.18 $ (0.22) $ 0.14 $ (0.13)
Diluted (in dollars per share) $ 0.18 $ (0.22) $ 0.14 $ (0.13)
Weighted average common shares outstanding:        
Basic (in shares) 199.7 199.3 199.8 199.2
Diluted (in shares) 200.5 199.3 200.8 199.2